Skip to main content

Ad Scientiam announces clinical validation of its MSCopilot® solution

MSCopilot®, Ad Scientiam's solution for monitoring patients with Multiple Sclerosis, has been clinically compared to Multiple Sclerosis Functional Composite (MSFC) standard tests.

This is the successful outcome of a 4-year R&D effort: MSCopilot® is a CE-marked, Class-I software medical device dedicated to the monitoring of patients with multiple sclerosis. It was developed in collaboration with physicians and patients and has received institutional support from Roche France.

 

Read the press release

 

 

Latest News

No news available.